X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
melanoma (56) 56
humans (55) 55
index medicus (48) 48
oncology (42) 42
male (35) 35
female (34) 34
middle aged (30) 30
immunotherapy (26) 26
aged (25) 25
cancer (25) 25
ipilimumab (24) 24
adult (23) 23
dermatology (23) 23
metastatic melanoma (22) 22
melanoma - drug therapy (20) 20
human necessities (19) 19
hygiene (19) 19
medical or veterinary science (19) 19
preparations for medical, dental, or toilet purposes (19) 19
pembrolizumab (18) 18
skin (18) 18
therapy (17) 17
metastasis (16) 16
nivolumab (16) 16
skin cancer (15) 15
aged, 80 and over (14) 14
animals (14) 14
care and treatment (14) 14
immunology (14) 14
skin neoplasms - drug therapy (14) 14
antibodies, monoclonal - therapeutic use (13) 13
biochemistry (13) 13
melanoma - pathology (13) 13
microbiology (13) 13
patients (13) 13
survival (13) 13
chemistry (12) 12
medicine, research & experimental (12) 12
analysis (11) 11
antibodies, monoclonal - adverse effects (11) 11
beer (11) 11
compositions thereof (11) 11
culture media (11) 11
enzymology (11) 11
metallurgy (11) 11
microorganisms or enzymes (11) 11
mutation or genetic engineering (11) 11
propagating, preserving or maintaining microorganisms (11) 11
retrospective studies (11) 11
specific therapeutic activity of chemical compounds ormedicinal preparations (11) 11
spirits (11) 11
vinegar (11) 11
wine (11) 11
antineoplastic agents - adverse effects (10) 10
antineoplastic agents - therapeutic use (10) 10
complications and side effects (10) 10
melanoma - therapy (10) 10
cell death (9) 9
immune checkpoint (9) 9
metastases (9) 9
mice (9) 9
treatment outcome (9) 9
immunotherapy - methods (8) 8
interleukin-12 - genetics (8) 8
malignant-melanoma (8) 8
melanoma - secondary (8) 8
programmed cell death 1 receptor - antagonists & inhibitors (8) 8
risk factors (8) 8
safety (8) 8
skin neoplasms - pathology (8) 8
advanced melanoma (7) 7
antibodies (7) 7
apoptosis (7) 7
biomarker (7) 7
braf (7) 7
cell lung-cancer (7) 7
cutaneous melanoma (7) 7
diagnosis (7) 7
hematology, oncology and palliative medicine (7) 7
inhibitors (7) 7
medical prognosis (7) 7
medicine (7) 7
medizinische fakultät (7) 7
melanoma - genetics (7) 7
myocarditis (7) 7
neoplasm metastasis (7) 7
regression analysis (7) 7
research (7) 7
research article (7) 7
survival analysis (7) 7
tumors (7) 7
young adult (7) 7
internal medicine (6) 6
lymphocytes (6) 6
melanoma - mortality (6) 6
prognosis (6) 6
radiation (6) 6
usage (6) 6
vemurafenib (6) 6
adverse events (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Deutsches Aerzteblatt Online, ISSN 1866-0452, 05/2019
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53745
Journal Article
Deutsches Arzteblatt international, 05/2019, Volume 116, Issue 20, p. 363
Journal Article
Deutsches Ärzteblatt International, 5/2019, Volume 116, Issue 20, pp. 363 - 363
Journal Article
Anticancer Research, ISSN 0250-7005, 03/2018, Volume 38, Issue 3, p. 1335
Background/Aim: Recent evidence suggests that melanoma patients treated with BRAF inhibitors experience radiosensitization with an increased frequency of... 
Biotechnology | Ionizing radiation | Inhibitors | Radiosensitization | Cell survival | Cell death | Test procedures | Melanoma | Tumor cell lines | Survival | Necrosis
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 11, p. e111237
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2019, Volume 144, Issue 5, pp. 1147 - 1150
Recent studies suggest that the age‐related remodeling of the immune system, known as immunosenescence, could impact the efficacy of immune checkpoint... 
melanoma | immunosenescence | immune checkpoint inhibitors | biomarker | BIOMARKERS | CELLS | ONCOLOGY | CD57 antigen | CD27 antigen | Flow cytometry | Therapy | Phenotypes | Senescence | Leukemia | Lung cancer | Melanoma | Lymphocytes T | CD28 antigen | Patients | Metastases | Inhibitors | Immune checkpoint | Lymphocytes | Correlation analysis | Phenotyping | Peripheral blood | Biomarkers | Immunosenescence | Surface markers | Immune system
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A699 - A699
Major adverse cardiac events (MACE) were defined as a composite of cardiovascular death, cardiogenic shock, cardiac arrest and complete heart block. Conclusion... 
Myocarditis | Heart diseases | Immune checkpoint
Journal Article
Clinical and translational allergy, ISSN 2045-7022, 2013, Volume 3, Issue 1, pp. 1 - 10
Skin prick testing is an essential test procedure to confirm sensitization in IgE-mediated allergic disease in subjects with rhinoconjunctivitis, asthma,... 
Diagnostic test | Type I allergy | Skin prick test panel | Aallergies | Sensitization | Asthma | Inhalant allergens | Allergy | Allergens | Meetings | Analysis | Immunoglobulin E | Skin | Allergic reaction
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21573 - e21573
Journal Article
Anticancer Research, ISSN 0250-7005, 03/2018, Volume 38, Issue 3, pp. 1335 - 1341
Background/Aim: Recent evidence suggests that melanoma patients treated with BRAF inhibitors experience radiosensitization with an increased frequency of... 
Vemurafenib | V600E mutant BRAF | Melanoma | Dabrafenib | BRAF inhibitor | BRAF | Radiotherapy | SURVIVAL | ONCOLOGY | radiotherapy | vemurafenib | MUTATIONS | dabrafenib | STRATEGIES
Journal Article
BMC CANCER, ISSN 1471-2407, 03/2019, Volume 19, Issue 1, pp. 207 - 7
BackgroundThe role of eosinophils in cancer is not yet completely understood, but patients with eosinophilia show a trend towards longer survival in several... 
CELLS | Biomarker | Prognosis | MIA | Melanoma | Eosinophil cationic protein (ECP) | SERUM | CANCER | INFILTRATION | METASTATIC MELANOMA | LDH | ECP | ONCOLOGY | CARCINOMA | Eosinophils
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 03/2017, Volume 29, Issue 2, pp. 136 - 144
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 10/2019, Volume 145, Issue 10, pp. 2625 - 2631
Immune checkpoint inhibitors (ICIs) are effective against a wide variety of cancers. However, they also induce a plethora of unique immune-related adverse... 
C-reactive protein | Medicine & Public Health | Hematology | Adverse events | Melanoma | Oncology | Cancer Research | Internal Medicine | Immune checkpoint inhibitors | SURVIVAL | SAFETY | ANTIBODY | TOXICITY | PEMBROLIZUMAB | ONCOLOGY | BLOCKADE | IPILIMUMAB | BLOOD | Proteins | Complications and side effects | Medical research | Analysis | Communicable diseases | Medicine, Experimental | Development and progression
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2016, Volume 14, Issue 7, pp. 662 - 683
Zusammenfassung CTLA‐4 und PD‐1 sind mögliche Angriffspunkte für eine Tumor‐bedingte Herunterregulation lymphozytärer Immunantworten.... 
Antigens | Hepatitis | Cell death
Journal Article
Journal Article